Drug firms have become the largest sponsors of medical research, generating vast amounts of valuable information through their efforts — but the companies’ enormous control over when, where and how that data is reported may not serve patients’ best interests, according to the authors of a report in the latest issue of The Lancet.
The pharmaceutical industry dedicates more time and resources to creating, gathering and disseminating information than to actually producing medicines, the authors write in the report. In part, drugmakers do so in order to satisfy licensing requirements, protect patents and obtain regulatory approvals. But companies also use the data to promote sales and educate patients and physicians about their medicines, in the process influencing prescribing practices and the direction of medical research.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!